Twitter LinkedIn
    Friday, February 3
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»IPO»General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO
    IPO

    General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO

    May 24, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Centessa Pharmaceuticals Plc, the newly formed biopharma company backed by private equity firm General Atlantic, said on Monday it was aiming for a valuation of up to $1.7 billion in its initial public offering in the United States.

    Formed in October, Centessa received $250 million funding in January. It is also backed by venture capital firm Index Ventures and life sciences-focused investment firm Medicxi.

    Moncef Slaoui, formerly the chief scientific adviser for the U.S. government’s Operation Warp Speed COVID-19 vaccine development program, joined Centessa as its chief scientific officer in February.

    Morgan Stanley, Goldman Sachs, Jefferies and Evercore ISI are the underwriters for the offering. Centessa said it would list on the Nasdaq under the symbol “CNTA”.

    Read More

    Source: Reuters

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    IPO PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Carlyle targeting $1.6B for second renewables fund

    November 18, 2022

    Comments are closed.

    Other Articles

    Hong Kong Buyout Firm EmergeVest Plans $250 Million SPAC

    March 29, 2021

    Goldman Sachs chases stake in £700m financial advice platform Nucleus

    March 11, 2022

    Lead Edge Capital raises USD1.95bn for Fund VI

    April 7, 2022

    TA Associates revives sale of $1B cosmetics firm Vivacy

    August 15, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?